The snakebite drug CroFab, which has been on the market since 2000, now faces competition from a drug called Anavip. But both are expensive.
snakes
Hatchling marine iguana versus hungry pit of racer snakes: Who will win?
The snakebite drug CroFab, which has been on the market since 2000, now faces competition from a drug called Anavip. But both are expensive.
Hatchling marine iguana versus hungry pit of racer snakes: Who will win?